Use of S-nitrosothiol signaling to treat disordered control of breathing

Details for Australian Patent Application No. 2002326573 (hide)

Owner University of Virginia Patent Foundation University of Louisville Research Foundation, Inc.

Inventors Gaston, Benjamin M; Gozal, David

Agent Davies Collison Cave

Pub. Number AU-B-2002326573

PCT Number PCT/US02/25199

PCT Pub. Number WO2003/015605

Priority 60/313,548 20.08.01 US

Filing date 12 August 2002

Wipo publication date 3 March 2003

Acceptance publication date 2 October 2008

International Classifications

A61K 31/10 (2006.01)

A61K 31/145 (2006.01) - having sulfur atoms, e.g. thiurams (NC(S)SC(S)N or NC(S)SSC(S)N)

A61K 31/16 (2006.01) - Amides, e.g. hydroxamic acids

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

Event Publications

23 January 2003 Complete Application Filed

  Priority application(s): 60/313,548 20.08.01 US

29 May 2003 Application Open to Public Inspection

  Published as AU-B-2002326573

2 October 2008 Application Accepted

  Published as AU-B-2002326573

5 February 2009 Standard Patent Sealed

8 March 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002326574-Tissue marking apparatus and method

2002326572-MULTIPLE-INTERFEROMETER DEVICE FOR WAVELENGTH MEASURING AND LOCKING